Lv11
40 积分 2023-04-28 加入
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
5小时前
待确认
Population Norms for SF-6Dv2 and EQ-5D-5L in China
9天前
已完结
Cost-Effectiveness of Aortic Valve Replacement in Low- and Intermediate-Risk Chinese Patients With Severe Aortic Stenosis
19天前
已完结
Health literacy, treatment adherence, bone mass density and health-related quality of life among Iranian older adults with osteoporosis
2年前
已完结
皖公网安备34019202002308
